Literature DB >> 27034638

Advances in 2D and 3D in vitro systems for hepatotoxicity testing.

Seddik Hammad1.   

Abstract

Entities:  

Year:  2013        PMID: 27034638      PMCID: PMC4803014     

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


× No keyword cloud information.

Dear Editor, Currently, much enthusiasm surrounds the establishment of hepatocyte in vitro systems as alternatives for animal experiments (Parrott et al., 2011[22]; Schaap et al., 2012[24]; Hammad et al., 2013[13]; Oloyede et al., 2013[21]). It has been shown that hepatocytes under certain culture conditions form 'microtissue' with some features similar to the in vivo situation (Rago et al., 2009[23]; Achilli et al., 2012[1]; Messner et al., 2013[20]). Moreover, precursor cells including embryonic stem cells can be differentiated to share some features with primary hepatocytes (Brulport et al., 2007[5]; Aurich et al., 2009[2]; Gabriel et al., 2012[7]; Seeliger et al., 2013[27]). The transcriptome of hepatocytes in vitro has been systematically compared to the in vivo situation (Godoy et al., 2010[12]; Zellmer et al., 2010[31]; Doktorova et al., 2012[6]; Godoy and Bolt, 2012[9]; Schug et al., 2013[26]). Despite some differences response patterns of hepatocyte in vitro nevertheless give relevant insight into the toxic mode of action of chemicals (Hewitt et al., 2007[15]; Bauer et al., 2009[3]; Ullrich et al., 2009[29]; Heise et al., 2012[14]; Knobeloch et al., 2012[18]). Although there are large differences to primary hepatocytes, hepatoma derived cells still represent a useful and easy to handle system that can be helpful if one is aware of the limitations (Watanabe et al., 2011[30]; Lin et al., 2012[19]; Schreck et al., 2012[25]; Tolosa et al., 2013[28]). Last but not least, systems biology techniques have successfully supported the current progress in hepatotoxicity testing (Hoehme et al., 2007[17], 2010[16]; Braeuning et al., 2010[4]; Geenen et al., 2012[8]). In this gold-rush mood currently prevailing in the field of hepatocyte in vitro systems an expert panel has recently published the probably most comprehensive review on the topic (Godoy et al., 2013[11]). The more than 100-page article critically discusses the possibilities and limitations of liver in vitro systems with particular emphasis on hepatotoxicity testing. The reader learns how the physiological state of hepatocytes is altered when they are isolated from their in vivo microenvironment and are brought into culture (Godoy et al., 2009[10], 2010[12], 2013[11]). Different culture systems and their advantages as well as limitations are critically reviewed, including monolayer cultures, sandwich cultures, co-cultures with non-parenchymal cells, spheroids or 'microtissue', liver slice cultures and the isolated perfused liver. A particular emphasis is given how to use these in vitro systems for studies of apoptosis and drug induced liver toxicity. Moreover, alternative hepatocyte sources, such as stem cell or hepatoma derived hepatocyte-like cells are critically discussed. The review of Godoy et al. (2013[11]) is of high interest for anyone interested in liver physiology as well as hepatotoxicity testing.
  29 in total

1.  Dissecting modes of action of non-genotoxic carcinogens in primary mouse hepatocytes.

Authors:  Mirjam M Schaap; Edwin P Zwart; Paul F K Wackers; Ilse Huijskens; Bob van de Water; Timo M Breit; Harry van Steeg; Martijs J Jonker; Mirjam Luijten
Journal:  Arch Toxicol       Date:  2012-06-19       Impact factor: 5.153

2.  Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration.

Authors:  Stefan Hoehme; Marc Brulport; Alexander Bauer; Essam Bedawy; Wiebke Schormann; Matthias Hermes; Verena Puppe; Rolf Gebhardt; Sebastian Zellmer; Michael Schwarz; Ernesto Bockamp; Tobias Timmel; Jan G Hengstler; Dirk Drasdo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-19       Impact factor: 11.205

Review 3.  Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

Authors:  Nicola J Hewitt; María José Gómez Lechón; J Brian Houston; David Hallifax; Hayley S Brown; Patrick Maurel; J Gerald Kenna; Lena Gustavsson; Christina Lohmann; Christian Skonberg; Andre Guillouzo; Gregor Tuschl; Albert P Li; Edward LeCluyse; Geny M M Groothuis; Jan G Hengstler
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

4.  Human hepatocytes: isolation, culture, and quality procedures.

Authors:  Daniel Knobeloch; Sabrina Ehnert; Lilianna Schyschka; Peter Büchler; Michael Schoenberg; Jörg Kleeff; Wolfgang E Thasler; Natascha C Nussler; Patricio Godoy; Jan Hengstler; Andreas K Nussler
Journal:  Methods Mol Biol       Date:  2012

5.  Analysis of arsenic metabolites in HepG2 and AS3MT-transfected cells.

Authors:  Takayuki Watanabe; Yuki Ohta; Ayano Mizumura; Yayoi Kobayashi; Seishiro Hirano
Journal:  Arch Toxicol       Date:  2011-05-03       Impact factor: 5.153

6.  Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis.

Authors:  Patricio Godoy; Jan G Hengstler; Iryna Ilkavets; Christoph Meyer; Anastasia Bachmann; Alexandra Müller; Gregor Tuschl; Stefan O Mueller; Steven Dooley
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

7.  Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers.

Authors:  Marc Brulport; Wiebke Schormann; Alexander Bauer; Matthias Hermes; Carolin Elsner; Friedrich Jakob Hammersen; Walter Beerheide; Dimitry Spitkovsky; Wolfgang Härtig; Andreas Nussler; Lars Christian Horn; Jeanett Edelmann; Oliver Pelz-Ackermann; Jörg Petersen; Manja Kamprad; Marc von Mach; Amelie Lupp; Henryk Zulewski; Jan G Hengstler
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

8.  HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.

Authors:  Laia Tolosa; M José Gómez-Lechón; Gabriela Pérez-Cataldo; José V Castell; M Teresa Donato
Journal:  Arch Toxicol       Date:  2013-02-09       Impact factor: 5.153

9.  Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo.

Authors:  H Aurich; M Sgodda; P Kaltwasser; M Vetter; A Weise; T Liehr; M Brulport; J G Hengstler; M M Dollinger; W E Fleig; B Christ
Journal:  Gut       Date:  2008-11-20       Impact factor: 23.059

10.  Differentiation and selection of hepatocyte precursors in suspension spheroid culture of transgenic murine embryonic stem cells.

Authors:  Elke Gabriel; Stephanie Schievenbusch; Eugen Kolossov; Jan G Hengstler; Tamara Rotshteyn; Heribert Bohlen; Dirk Nierhoff; Jürgen Hescheler; Irina Drobinskaya
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

View more
  5 in total

1.  Optimisation of the HepaRG cell line model for drug toxicity studies using two different cultivation conditions: advantages and limitations.

Authors:  Marc Ruoß; Andreas K Nüssler; Mohammad Majd Hammour; Amnah Othman; Romina Aspera-Werz; Bianca Braun; Michaela Weis-Klemm; Silvia Wagner; Silvio Nadalin; Tina Histing
Journal:  Arch Toxicol       Date:  2022-06-24       Impact factor: 6.168

2.  Highlight report: Necrosis-apoptosis conundrum of hepatocytes: mode of hepatocyte death after acetaminophen intoxication.

Authors:  Ahmed Ghallab
Journal:  EXCLI J       Date:  2018-12-19       Impact factor: 4.068

3.  Performance metrics of in vitro tests.

Authors:  Florian Seidel
Journal:  EXCLI J       Date:  2019-08-07       Impact factor: 4.068

4.  Recent developments in animal sciences.

Authors:  Seddik Hammad; Isabelle Sobor; Mohammed F Abdallah; Ahmed A A Abdel-Wareth; Mohammad S Al-Aboody; Mosaab A Omar
Journal:  EXCLI J       Date:  2015-05-11       Impact factor: 4.068

5.  Highlight report: Software for tissue analysis and reconstruction.

Authors:  Mohie A M Haridy; Yasser S El-Sayed
Journal:  EXCLI J       Date:  2015-09-23       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.